131858-37-2Relevant articles and documents
SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5
-
Page/Page column 55; 64-65, (2021/04/10)
Disclosed are compounds having structural formula I, and related salts and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases and conditions such as kidney disease, kidney failure, kidney stones, or polycystic kidney disease, using the compounds of formula (I), and related salts and pharmaceutical compositions.
Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome
Wilson, David L.,Meininger, Isabel,Strater, Zack,Steiner, Stephanie,Tomlin, Frederick,Wu, Julia,Jamali, Haya,Krappmann, Daniel,G?tz, Marion G.
supporting information, p. 250 - 255 (2016/03/25)
This research explores the first design and synthesis of macrocyclic peptide aldehydes as potent inhibitors of the 20S proteasome. Two novel macrocyclic peptide aldehydes based on the ring-size of the macrocyclic natural product TMC-95 were prepared and e
N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS
-
Page/Page column 110-111, (2009/04/25)
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such interm